Biochemical Action of Vaccines in Iraqi Patients with COVID-19 Infection

Author:

Jasim Rasha ZuhairORCID

Abstract

      The aim of the present study is to compare the biochemical action of the three vaccines taken in Iraq: Pfizer Biontech, AstraZeneca Oxford and Sinopharm based on biochemical parameters. Seventy COVID-19 Iraqi patients ( males and females ) were participated in the present study and classified into 7 groups : Gc :  COVID-19 patients ( without vaccine ) , Gp1: COVID-19 patients took one dose of Pfizer Biontech, Gp2 : COVID-19 patients took two doses of Pfizer Biontech, Ga1 : patients took one dose of AstraZeneca Oxford vaccine , Ga2: patients took two doses of AstraZeneca Oxford vaccine , Gs1 : patients took one dose of Sinopharm vaccine and Gs2: patients took two doses of Sinopharm vaccine. Patients were compared with healthy subjects (without vaccine) as a control group (Gh). The D-dimer level was highly significantly increased in Gc compared with Gh and was highly significantly decreased in Gp1 , Ga1 , Ga2 , significantly decreased in Gp2 and non-significantly decreased in Gs1 and highly significant increased in Gs2 compared with Gc. CRP level was significantly increased in Gc compared with Gh while it was significantly decreased in Gp1, Gp2, Ga1 , Ga2 , Gs1 , Gs2 compared with Gc. IgG and IgM levels were increased in Gc but decreased after taking vaccines ( except Ga2 for IgG and Gp2 for IgM )   The present study submits a novelty to the field of COVID-19 by highlighting the chemical aspects of vaccines used in Iraq

Publisher

College of Science for Women

Subject

General Physics and Astronomy,Agricultural and Biological Sciences (miscellaneous),General Biochemistry, Genetics and Molecular Biology,General Mathematics,General Chemistry,General Computer Science

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Editorial: Current advances in anti-infective strategies;Baghdad Science Journal;2023-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3